alanine has been researched along with olanzapine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akin, F; Aydin, N; Barlas, O; Erdal, M; Herken, H; Karadag, F; Sengul, C | 1 |
| Bidder, M; Gil-Ad, I; Kramer, M; Portnoy, M; Taler, M; Tarasenko, I; Weizman, A | 1 |
| Gil-Ad, I; Globus, R; Shbiro, L; Taler, M; Vered, I; Weizman, A; Weller, A | 1 |
3 other study(ies) available for alanine and olanzapine
| Article | Year |
|---|---|
The association of olanzapine-induced weight gain with peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism in patients with schizophrenia.
Topics: Adult; Alanine; Antipsychotic Agents; Base Sequence; Benzodiazepines; DNA Primers; Humans; Middle Aged; Olanzapine; PPAR gamma; Proline; Schizophrenia; Weight Gain | 2009 |
A novel analog of olanzapine linked to sarcosinyl moiety (PGW5) demonstrates high efficacy and good safety profile in mouse models of schizophrenia.
Topics: Alanine; Amphetamine; Animals; Antipsychotic Agents; Anxiety; Benzodiazepines; Brain; Central Nervous System Stimulants; Depression; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Excitatory Amino Acid Antagonists; Exploratory Behavior; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Motor Activity; Olanzapine; Phencyclidine; Psychomotor Agitation; Schizophrenia; Social Behavior | 2014 |
Attenuated Weight Gain with the Novel Analog of Olanzapine Linked to Sarcosinyl Moiety (PGW5) Compared to Olanzapine.
Topics: Alanine; Animals; Antipsychotic Agents; Benzodiazepines; Female; Hypothalamus; Olanzapine; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Sarcosine; Weight Gain | 2016 |